STX2 and hemolytic-uremic syndrome: In line with this, we found that the number of Stx2-bearing monocytes was strikingly increased in both peripheral blood and kidney in Stx2/LPS-treated mice, suggesting that LPS priming may facilitate HUS development via increasing the binding affinity of monocytes to Stx2 or the chemotaxis of monocytes to mouse kidney.